FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+6.19%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$9.98B
AUM Growth
+$9.98B
(+4.1%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
51.68%
Holding
103
New
18
Increased
35
Reduced
17
Closed
19
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$941M |
| 2 |
COL
Rockwell Collins
COL
|
$343M |
| 3 |
MON
Monsanto Co
MON
|
$158M |
| 4 |
Elevance Health
ELV
|
$138M |
| 5 |
Charter Communications
CHTR
|
$91.5M |
Top Sells
| 1 |
BCR
CR Bard Inc.
BCR
|
$508M |
| 2 |
TWX
Time Warner Inc
TWX
|
$380M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
$196M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
$175M |
| 5 |
ALR
Alere Inc
ALR
|
$138M |
Sector Composition
| 1 | Technology | 27.73% |
| 2 | Healthcare | 17.2% |
| 3 | Communication Services | 17.19% |
| 4 | Financials | 14.55% |
| 5 | Industrials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Liberty Global Class C
LBTYK
$4.05B
| $139M | 1.13% |
4,102,123
+1,012,350
| +33% | +$34.3M |
|
27
AstraZeneca
AZN
$253B
| $131M | 1.06% |
3,765,000
+585,000
| +18% | +$20.3M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $125M | 1.02% |
3,936,300
| – | – |
|
29
Liberty Global Class A
LBTYA
$3.98B
| $117M | 0.95% |
3,270,180
+277,245
| +9% | +$9.94M |
|
30
VEON
VEON
$3.87B
| $113M | 0.92% |
29,433,518
| – | – |
|
31
Huntsman Corp
HUN
$1.89B
| $80.7M | 0.66% |
2,425,000
-1,075,000
| -31% | -$35.8M |
|
32
FibroGen
FGEN
$48M
| $78.6M | 0.64% |
1,657,500
+557,500
| +51% | +$26.4M |
|
33
Bristol-Myers Squibb
BMY
$96.7B
| $73.1M | 0.59% |
1,192,500
-162,500
| -12% | -$9.96M |
|
|
AKRX
34
DELISTED
Akorn, Inc.
AKRX
| $72.6M | 0.59% |
2,251,300
-28,700
| -1% | -$925K |
|
35
AbbVie
ABBV
$374B
| $67.7M | 0.55% |
700,000
+115,000
| +20% | +$11.1M |
|
|
SAGE
36
DELISTED
Sage Therapeutics
SAGE
| $65.9M | 0.54% |
400,000
+156,500
| +64% | +$25.8M |
|
|
GNCMA
37
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $64.1M | 0.52% |
1,643,800
| – | – |
|
|
ABLX
38
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $58.7M | 0.48% |
+2,350,000
| New | +$58.7M |
|
39
AnaptysBio
ANAB
$606M
| $56.5M | 0.46% |
561,000
+315,000
| +128% | +$31.7M |
|
40
Enanta Pharmaceuticals
ENTA
$192M
| $54.3M | 0.44% |
925,000
+512,667
| +124% | +$30.1M |
|
41
Qualcomm
QCOM
$169B
| $50.6M | 0.41% |
789,783
+704,783
| +829% | +$45.1M |
|
|
XLRN
42
DELISTED
Acceleron Pharma Inc.
XLRN
| $46.2M | 0.38% |
1,088,000
+125,000
| +13% | +$5.31M |
|
43
Amicus Therapeutics
FOLD
$2.4B
| $40M | 0.33% |
2,781,000
-2,300,055
| -45% | -$33.1M |
|
|
MYOK
44
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $36.4M | 0.3% |
863,732
+466,232
| +117% | +$19.6M |
|
|
ZGNX
45
DELISTED
Zogenix, Inc.
ZGNX
| $34M | 0.28% |
850,000
+530,000
| +166% | +$21.2M |
|
|
RC
46
Ready Capital
RC
$693M
| $33.3M | 0.27% |
2,200,007
-124,229
| -5% | -$1.88M |
|
47
Savara
SVRA
$582M
| $33M | 0.27% |
2,225,000
| – | – |
|
48
Ionis Pharmaceuticals
IONS
$9.63B
| $32.4M | 0.26% |
645,000
+195,000
| +43% | +$9.81M |
|
49
Grifois
GRFS
$6.59B
| $32.3M | 0.26% |
1,408,760
-21,013
| -1% | -$482K |
|
50
Galapagos
GLPG
$2.05B
| $27.2M | 0.22% |
290,000
+53,784
| +23% | +$5.04M |
|